Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study
Crossref DOI link: https://doi.org/10.1007/s10067-017-3587-8
Published Online: 2017-03-02
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Desplats, Marie
Pascart, Tristan
Jelin, Germain
Norberciak, Laurène
Philippe, Peggy
Houvenagel, Eric
Goeb, Vincent
Flipo, René-Marc
License valid from 2017-03-02